Pasar al contenido principal

EL PAPEL DE LAS INTERACCIONES PROTEINA-PROTEINA Y PROTEINA-ACIDO NUCLEICA EN LA INFECCION VIRAL

PID2020-117976GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Symmetry disruption commits vault particles to disassembly

  • Guerra, Pablo
  • González-Alamos, María
  • Llauró, Aida
  • Casañas, Arnau
  • Querol-Audí, Jordi
  • Pablo, Pedro J. de
  • Verdaguer, Núria
Vaults are ubiquitous ribonucleoprotein particles involved in a diversity of cellular processes, with promising applications as nanodevices for delivery of multiple cargos. The vault shell is assembled by the symmetrical association of multiple copies of the major vault protein that, initially, generates half vaults. The pairwise, anti-parallel association of two half vaults produces whole vaults. Here, using a combination of vault recombinant reconstitution and structural techniques, we characterized the molecular determinants for the vault opening process. This process commences with a relaxation of the vault waist, causing the expansion of the inner cavity. Then, local disengagement of amino-terminal domains at the vault midsection seeds a conformational change that leads to the aperture, facilitating access to the inner cavity where cargo is hosted. These results inform a hitherto uncharacterized step of the vault cycle and will aid current engineering efforts leveraging vault for tailored cargo delivery., This work was supported by the Spanish Ministry for Science and Innovation (grants BIO2017-83906-P and PID2020-117976GB-I00), the Generalitat de Catalunya (grant 2017 SGR 01192), and the CSIC (grant 20202CEX003).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure and function of the NS5 methyltransferase domain from Usutu virus

  • Ferrero, Diego
  • Albentosa-González, Laura
  • Mas-Barreiro, Antonio
  • Verdaguer, Núria
Usutu virus (USUV), is a mosquito-borne flavivirus currently spreading outside the African continent producing substantial avian mortality. In contrast, infected humans could exhibit mild neurological symptoms or remain asymptomatic. As in other flaviviruses, the capped USUV genome encodes three structural and seven non-structural (NS) proteins. Among the NS proteins, NS5 plays crucial roles in virus replication, harbouring the capping and methyltransferase (MTase) activities in its N-terminal domain and the RNA-dependent RNA polymerase (RdRP) activity at the C-terminus. In this work, we present the first structural and functional characterization of the USUV MTase domain. The first structure of the USUV MTase has been determined in complex with its natural ligands (S-adenosyl-L-methionine [SAM]) and S-adenosyl-L-homocysteine [SAH]) at 2.2 Å resolution, showing a molecular dimer in the crystal asymmetric unit. One molecule is bound to the methyl donor SAM while the second is bound to the reaction by-product SAH. Both molecules are almost identical and also show a high structural similarity to the MTase domains of other flaviviruses. The structure of the USUV MTase bound to the inhibitor sinefungin at 1.8 Å resolution is also described. Careful comparisons of the interactions in the SAM-binding cavity prompt us to hypothesize about the strength and weakness of the structure-based design of antivirals directed to the SAM/SAH binding site that could be effective to deal with this threat., The work at Prof. Nuria Verdaguer lab was funded by the Spanish Ministry of Science and Innovation (PID2020-117976GB-I00). The work at Prof. Antonio Mas was funded by Spanish Ministry of Science and Innovation (SAF2016-80451-P and PID2019-106068GB-I00) and UCLM (2019-GRIN-27080)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dual role of the foot-and-mouth disease virus 3B1 protein in the replication complex: As protein primer and as an essential component to recruit 3Dpol to membranes

  • Ferrer-Orta, Cristina
  • Ferrero, Diego
  • Verdaguer, Núria
Picornavirus genome replication takes place in specialized intracellular membrane compartments that concentrate viral RNA and proteins as well as a number of host factors that also participate in the process. The core enzyme in the replication machinery is the viral RNA-dependent RNA polymerase (RdRP) 3Dpol. Replication requires the primer protein 3B (or VPg) attached to two uridine molecules. 3B uridylylation is also catalysed by 3Dpol. Another critical interaction in picornavirus replication is that between 3Dpol and the precursor 3AB, a membrane-binding protein responsible for the localization of 3Dpol to the membranous compartments at which replication occurs. Unlike other picornaviruses, the animal pathogen foot-and-mouth disease virus (FMDV), encodes three non-identical copies of the 3B (3B1, 3B2, and 3B3) that could be specialized in different functions within the replication complex. Here, we have used a combination of biophysics, molecular and structural biology approaches to characterize the functional binding of FMDV 3B1 to the base of the palm of 3Dpol. The 1.7 Å resolution crystal structure of the FMDV 3Dpol -3B1 complex shows that 3B1 simultaneously links two 3Dpol molecules by binding at the bottom of their palm subdomains in an almost symmetric way. The two 3B1 contact surfaces involve a combination of hydrophobic and basic residues at the N- (G5-P6, R9; Region I) and C-terminus (R16, L19-P20; Region II) of this small protein. Enzyme-Linked Immunosorbent Assays (ELISA) show that the two 3B1 binding sites play a role in 3Dpol binding, with region II presenting the highest affinity. ELISA assays show that 3Dpol has higher binding affinity for 3B1 than for 3B2 or 3B3. Membrane-based pull-down assays show that 3B1 region II, and to a lesser extent also region I play essential roles in mediating the interaction of 3AB with the polymerase and its recruitment to intracellular membranes., This work was funded by the Spanish Ministry of Science and Innovation grant PID2020-117976GB-I00 to NV.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural insights on the nucleoprotein C-terminal domain of Měnglà virus

  • Ferrero, Diego
  • Gilabert, Omar Tomás
  • Verdaguer, Núria
Filoviruses depend on the nucleoprotein (NP) to accomplish multiple functions during the viral life cycle. NP is the most abundantly expressed viral protein in infected cells and the main component of the viral nucleocapsid. It can be structurally divided into amino- and carboxy- terminal domains (NTD and CTD). The NTD can homo-oligomerize to interact and protect the (−) ssRNA genome, forming long helical structures. The flexible CTD is responsible for the binding of other nucleocapsid proteins and is involved in the formation of inclusion bodies (IBs)—the cytoplasmic sites of nucleocapsid formation and genome replication. The CTD ends in a ~100-residue globular tail. Měnglà virus (MLAV) is the only member of the new Dianlovirus genus within the Filoviridae family. Their differential characteristics and the possibility of becoming a threat for human health justify the interest in better understanding of its structure and function. In this work, we present the structure of the globular tail of the MLAV NP CTD, showing an overall conformation closely related to that previously reported for the equivalent NP region in MARV. Moreover, analyses of the CTD-CTD interactions in the crystal asymmetric unit revealed a higher-order helicoidal structure. Mutational studies underscore the crucial role of a number of residues, located at the CTD-CTD contact interface, for IB formation. Site-directed mutagenesis of amino acids L653 and F687, involved in the formation of these helicoidal assemblies, abrogate the growth of IBs when the full-length MLAV NP was ectopically expressed in cells. Our findings confirm the role of NP CTD in IB formation, also for MLAV, and focus the attention on particular residues as starting point for further analysis., This work was funded by the Spanish Ministry of Science and Innovation (PID2020-117976GB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synergism between remdesivir and ribavirin leads to SARS-CoV-2 extinction in cell culture

  • García-Crespo, Carlos
  • Ávila, Ana Isabel de
  • Gallego, Isabel
  • Soria, María Eugenia
  • Durán-Pastor, Antoni
  • Somovilla, Pilar
  • Martínez-González, Brenda
  • Muñoz-Flores, Javier
  • Mínguez, Pablo
  • Salar-Vidal, Llanos
  • Esteban-Muñoz, Mario
  • Cañar-Camacho, Elizabeth
  • Ferrer-Orta, Cristina
  • Zúñiga Lucas, Sonia
  • Solá Gurpegui, Isabel
  • Enjuanes Sánchez, Luis
  • Esteban, Jaime
  • Fernández-Roblas, Ricardo
  • Gadea, Ignacio
  • Gómez, Jordi
  • Verdaguer, Núria
  • Domingo, Esteban
  • Perales, Celia
[Background and Purpose] There is a need for effective anti-COVID-19 treatments, mainly for individuals at risk of severe disease such as the elderly and the immunosuppressed. Drug repositioning has proved effective in identifying drugs that can find a new application for the control of coronavirus disease, in particular COVID-19. The purpose of the present study was to find synergistic antiviral combinations for COVID-19 based on lethal mutagenesis., [Experimental Approach] The effect of combinations of remdesivir and ribavirin on the infectivity of SARS-CoV-2 in cell culture has been tested. Viral populations were monitored by ultra-deep sequencing, and the decrease of infectivity as a result of the treatment was measured., [Key Results] Remdesivir and ribavirin exerted a synergistic inhibitory activity against SARS-CoV-2, quantified both by CompuSyn (Chou-Talalay method) and Synergy Finder (ZIP-score model). In serial passage experiments, virus extinction was readily achieved with remdesivir-ribavirin combinations at concentrations well below their cytotoxic 50 value, but not with the drugs used individually. Deep sequencing of treated viral populations showed that remdesivir, ribavirin, and their combinations evoked significant increases of the number of viral mutations and haplotypes, as well as modification of diversity indices that characterize viral quasi-species., [Conclusion and Implications] SARS-CoV-2 extinction can be achieved by synergistic combination treatments based on lethal mutagenesis. In addition, the results offer prospects of triple drug treatments for effective SARS-CoV-2 suppression., The work was supported by the Span- ish Ministry of Science and Innovation, grants PID2020-117976GB- I00, PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116 and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC's Global Health Platform (PTI Salud Global). The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III co-funded by the European Union, CSIC-COV19-014 from Consejo Superior de Investigaciones Científicas (CSIC) and project 525/C/2021 from Fundacio La Marato de TV3, grants 202136-30 and 202136-31. We also acknowledge the project S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. A.D-P. is sup- ported by the contract 13-2022-008566 co-financed by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union - Next Generation EU. P.S. is supported by postdoc- toral contract Margarita Salas, CA1/RSUE/2021 from MCIU. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III co-financed by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), co-financed by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps

  • Delgado, Soledad
  • Somovilla, Pilar
  • Ferrer-Orta, Cristina
  • Martínez-González, Brenda
  • Vázquez-Monteagudo, Sergi
  • Muñoz-Flores, Javier
  • Soria, María Eugenia
  • García-Crespo, Carlos
  • Ávila, Ana Isabel de
  • Durán-Pastor, Antoni
  • Gadea, Ignacio
  • López-Galíndez, Cecilio
  • Morán, Federico
  • Lorenzo-Redondo, Ramón
  • Verdaguer, Núria
  • Perales, Celia
  • Domingo, Esteban
Since its introduction in the human population, SARS-CoV-2 has evolved into multiple clades, but the events in its intrahost diversification are not well understood. Here, we compare three-dimensional (3D) self-organized neural haplotype maps (SOMs) of SARS-CoV-2 from thirty individual nasopharyngeal diagnostic samples obtained within a 19-day interval in Madrid (Spain), at the time of transition between clades 19 and 20. SOMs have been trained with the haplotype repertoire present in the mutant spectra of the nsp12- and spike (S)-coding regions. Each SOM consisted of a dominant neuron (displaying the maximum frequency), surrounded by a low-frequency neuron cloud. The sequence of the master (dominant) neuron was either identical to that of the reference Wuhan-Hu-1 genome or differed from it at one nucleotide position. Six different deviant haplotype sequences were identified among the master neurons. Some of the substitutions in the neural clouds affected critical sites of the nsp12-nsp8-nsp7 polymerase complex and resulted in altered kinetics of RNA synthesis in an in vitro primer extension assay. Thus, the analysis has identified mutations that are relevant to modification of viral RNA synthesis, present in the mutant clouds of SARS-CoV-2 quasispecies. These mutations most likely occurred during intrahost diversification in several COVID-19 patients, during an initial stage of the pandemic, and within a brief time period., Institutional support from Global Management Solutions and valuable discussions are acknowledged. The work at UPM was supported by grants PID2019-104903RB-100 and PID2022-139908OB-I00, funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. The work at FJD was supported by project PI21/00139 from Instituto de Salud Carlos III, co-funded by the European Union. The work at CSIC was supported by PID2020-113888RB-I00, PID2020-117976GB-I00, and 202220I116 from Ministerio de Ciencia e Innovación and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). This research work was also funded by the European Commission – NextGenerationEU (regulation EU 2020/2094), through the CSIC’s Global Health Platform (PTI Salud Global), and Fundació La Marató de TV3 (project 525/C/2021), grants 202136-30 and 202136-31. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). Work at Centro Nacional de Microbiología (ISCIII) was supported by grants SAF2016-77894-R from MINECO and PI13/02269 from ISCIII. The work at Universidad Complutense Madrid has been supported by research grant CTQ2017-87864-C2-2-P, from MINECO. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from ISCIII, cofinanced by Fondo Social Europeo (FSE). A.D.-P. is supported by the contract 13-2022-008566 cofinanced by the Comunidad de Madrid, through the Programa Investigo, en el marco del Plan de Recuperación, Transformación y Resiliencia, financed by the European Union–Next Generation EU. P.S. is supported by postdoctoral contract “Margarita Salas” CA1/RSUE/2021 from MCIU. C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2

  • Ferrer-Orta, Cristina
  • Vázquez-Monteagudo, Sergi
  • Ferrero, Diego
  • Martínez-González, Brenda
  • Perales, Celia
  • Domingo, Esteban
  • Verdaguer, Núria
In a recent characterization of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variability present in 30 diagnostic samples from patients of the first COVID-19 pandemic wave, 41 amino acid substitutions were documented in the RNA-dependent RNA polymerase (RdRp) nsp12. Eight substitutions were selected in this work to determine whether they had an impact on the RdRp activity of the SARS-CoV-2 nsp12-nsp8-nsp7 replication complex. Three of these substitutions were found around the polymerase central cavity, in the template entry channel (D499G and M668V), and within the motif B (V560A), and they showed polymerization rates similar to the wild type RdRp. The remaining five mutations (P323L, L372F, L372P, V373A, and L527H) were placed near the nsp12-nsp8F contact surface; residues L372, V373, and L527 participated in a large hydrophobic cluster involving contacts between two helices in the nsp12 fingers and the long α-helix of nsp8F. The presence of any of these five amino acid substitutions resulted in important alterations in the RNA polymerization activity. Comparative primer elongation assays showed different behavior depending on the hydrophobicity of their side chains. The substitution of L by the bulkier F side chain at position 372 slightly promoted RdRp activity. However, this activity was dramatically reduced with the L372P, and L527H mutations, and to a lesser extent with V373A, all of which weaken the hydrophobic interactions within the cluster. Additional mutations, specifically designed to disrupt the nsp12-nsp8F interactions (nsp12-V330S, nsp12-V341S, and nsp8-R111A/D112A), also resulted in an impaired RdRp activity, further illustrating the importance of this contact interface in the regulation of RNA synthesis., This work was funded by the Spanish Ministry of Science and Innovation, grants PID2020-117976GB-I00, PID2020-113888RB-I00/AEI/10.13039/501100011033, and 202220I116 and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the CSIC’s Global Health Platform (PTI Salud Global). The grants PI21/00139 from Instituto de Salud Carlos III cofunded by the European Union, S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER), CSIC-COV19-014 from CSIC and from Fundació La Marató de TV3, grants 202136-30 and 202136-31, also support this work. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure of the aminoterminal domain of the birnaviral multifunctional VP3 protein and its unexplored critical role

  • Ferrero, Diego
  • Giménez. María Cecilia
  • Sagar, Amin
  • Rodríguez, Javier M.
  • Castón, José R.
  • Terebiznik, Mauricio R.
  • Bernadó, Pau
  • Verdaguer, Núria
To overcome their limited genetic capacity, numerous viruses encode multifunctional proteins. The birnavirus VP3 protein plays key roles during infection, including scaffolding of the viral capsid during morphogenesis, recruitment, and regulation of the viral RNA polymerase, shielding of the double-stranded RNA genome and targeting of host endosomes for genome replication, and immune evasion. The dimeric form of VP3 is critical for these functions. In previous work, we determined the X-ray structure of the central domains (D2–D3) of VP3 from the infectious bursal disease virus (IBDV). However, the structure and function of the IBDV VP3 N-terminal domain (D1) could not be determined at that time. Using integrated structural biology approaches and functional cell assays, here we characterize the IBDV VP3 D1 domain, unveiling its unexplored roles in virion stability and infection. The X-ray structure of D1 shows that this domain folds in four α-helices arranged in parallel dimers, which are essential for maintaining the dimeric arrangement of the full-length protein. Combining small-angle X-ray scattering analyses with molecular dynamics simulations allowed us to build a structural model for the D1–D3 domains. This model consists of an elongated structure with high flexibility in the D2–D3 connection, keeping D1 as the only driver of VP3 dimerization. Using reverse genetics tools, we show that the obliteration of D1 domain prevents the VP3 scaffold function during capsid assembly and severely impacts IBDV infection. Altogether, our study elucidates the structure of the VP3 D1 domain and reveals its role in VP3 protein dimerization and IBDV infection., The work at IBMB was funded by the Spanish Ministry of Science and Innovation (PID2020-117976GB-I00). The work at the CBS was funded by Labex EpiGenMed, an “Investissements d’avenir” program (ANR-10-LABX-12-01). The work at the CNB was supported by grants from the Spanish Ministry of Science and Innovation (PID2020-113287RB-I00) and the Comunidad Autónoma de Madrid (P2018/NMT-4389) to J.R.C. Mauricio R. Terebiznik funding to this project was provided by the Discovery Grants programs RGPIN-2018-05734 and RGPAS2018-522692 from the Natural Sciences and Engineering Research Council of Canada (NSERC). X-ray data were collected at ESRF, beamline ID29 (ESRF, Grenoble, France), and XALOC (ALBA, Cerdanyola del Vallés, Spain). SAXS data were collected at EMBL-bioSAXS P12 Beamline at Petra III storage ring (Hamburg) and BM29 BioSAXS beamline at ESRF (Grenoble). Financial support was provided by Instruct-ERIC (PID6902) for access to Hamburg synchrotron. The CBS is a member of France-BioImaging (FBI) and the French Infrastructure for Integrated Structural Biology (FRISBI), two national infrastructures supported by the French National Research Agency (ANR-10-INBS-04-01 and ANR-10-INBS-05, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Structure, Dynamics and Functional Implications of the Eukaryotic Vault Complex

  • González-Alamos, María
  • Guerra, Pablo
  • Verdaguer, Núria
Vault ribonucleoprotein particles are naturally designed nanocages, widely found in the eukaryotic kingdom. Vaults consist of 78 copies of the major vault protein (MVP) that are organized in 2 symmetrical cup-shaped halves, of an approximate size of 70x40x40 nm, leaving a huge internal cavity which accommodates the vault poly(ADP-ribose) polymerase (vPARP), the telomerase-associated protein-1 (TEP1) and some small untranslated RNAs. Diverse hypotheses have been developed on possible functions of vaults, based on their unique capsular structure, their rapid movements and the distinct subcellular localization of the particles, implicating transport of cargo, but they are all pending confirmation. Vault particles also possess many attributes that can be exploited in nanobiotechnology, particularly in the creation of vehicles for the delivery of multiple molecular cargoes. Here we review what is known about the structure and dynamics of the vault complex and discuss a possible mechanism for the vault opening process. The recent findings in the characterization of the vaults in cells and in its natural microenvironment will be also discussed., This work was funded by the Spanish Ministry of Science and Innovation (PID2020-117976GB-I00) to NV. MGA work is supported by a predoctoral contract PRE2018-083964 from Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

X-Ray Crystallography of Viruses

  • Verdaguer, Núria
  • Ferrer-Orta, Cristina
  • Garriga, Damià
Since the 1970s and for about 40 years, X-ray crystallography has been by far the most powerful approach for determining virus structures at close to atomic resolutions. Information provided by these studies has deeply and extensively enriched and shaped our vision of the virus world. In turn, the ever-increasing complexity and size of the virus structures being investigated have constituted a major driving force for methodological and conceptual developments in X-ray macromolecular crystallography (MX). Landmarks of the structure determination of viral particles, such as the ones from the first animal viruses or from the first membrane-containing viruses, have often been associated with methodological breakthroughs in X-ray crystallography. In recent years, the advent of new detectors with fast frame rate, high sensitivity, and low-noise background has changed the way MX data is collected, enabling new types of studies at X-ray free-electron laser and synchrotron facilities. In parallel, a very high degree of automation has been established at most MX synchrotron beamlines, allowing the screening of large number of crystals with very high throughputs. This has proved crucial for fragment-based drug design projects, of special relevance for the identification of new antiviral drugs. This change in the usage of X-ray crystallography is also mirrored in the recent advances in cryo-electron microscopy (cryo-EM), which can nowadays produce macromolecule structures at resolutions comparable to those obtained by MX. Since this technique is especially amenable for large protein assemblies, cryo-EM has progressively turned into the favored technique to study the structure of large viral particles at high resolution. In this chapter, we present the common ground of proteins and virus crystallography with an emphasis in the peculiarities of virus-related studies., This work was supported by grant PID2020-117976GB-100 from the Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait

  • Martínez-González, Brenda
  • Soria, María Eugenia
  • Ávila, Ana Isabel de
  • Somovilla, Pilar
  • Aguilar-Sabido, Claudia
  • Mínguez, Pablo
  • Ferrer-Orta, Cristina
  • Salar-Vidal, Llanos
  • Lorenzo-Redondo, Ramón
  • Delgado, Soledad
  • Morán, Federico
  • Verdaguer, Núria
  • Gadea, Ignacio
  • Domingo, Esteban
  • Perales, Celia
RNA virus populations consist of complex and dynamic mutant spectra in which most individual genomes differ in one or more positions from the other genomes of the same population. This behavior, known as quasispecies dynamics, applies to SARS-CoV-2 which exhibits intrahost genetic and functional heterogeneity while evolving at a high rate in the human population. In the present study, we describe a remarkable reduction in mutant spectrum complexity (intrahost viral genome heterogeneity) in SARS-CoV-2 isolates of late relative to early COVID-19 waves, as they reached Madrid (Spain) from 2020 until 2022. In contrast, the consensus (average) sequence of the corresponding isolates displayed a continuing divergence from the initial Wuhan-Hu-1 virus as the pandemic advanced. The mutant spectrum complexity developed upon replication in Vero E6 cells of the isolates from the first and sixth COVID-19 waves, as well as of biological clones retrieved from them, was similar. Therefore, the mutant spectrum complexity reduction observed in vivo was not due to an increased accuracy of the viral replicative machinery, but rather to other factors related to viral epidemiology or pathogenesis. Such possible factors and their implications for viral trait modifications in the course of a viral pandemic are discussed. The results establish that mutant spectrum complexity of genetically variable viruses can be an epidemiologically evolvable trait., This work was supported by the Spanish Ministry of Science and Innovation, grants PID2020-117976GB-I00, PID2020-113888RB-I00/AEI/10.13039/501100011033 and 202220I116, by the Ministerio de Ciencia, Innovación y Universidades (MICIU), grant PID2023-146622OB-I00 financed by MICIU/AEI/10.13039/501100011033, by Fondo Europeo de Desarrollo Regional (FEDER), UE, through the “Severo Ochoa” Program for Centres of Excellence in Research and Development (CEX2021-001154-S), and by the European Commission-Next Generation EU (regulation EU 2020/2024) through the Consejo Superior de Investigaciones Científicas (CSIC’s) Global Health Platform [Plataforma Temática Interdisciplinar (PTI) Salud Global]. The work was also funded by grants PI21/00139 from Instituto de Salud Carlos III, CSIC-COV19-014 from CSIC and project 525/C/2021 from Fundació La Marató de TV3, grants 202136-30 and 202136-31. We also acknowledge the projects TEC-2024/BIO-66 (SALAINDEC-CM from Comunidad de Madrid/FEDER) and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBM are also acknowledged. The team at Centro de Biología Molecular (CBM) belongs to the Global Virus Network, and to the Biomedicine Unit of Universidad de Castilla La Mancha, associated with CSIC. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III cofinanced by Fondo Social Europeo (FSE), “El FSE invierte en tu futuro.” P.S. is supported by postdoctoral contract Margarita Salas, CA1/RSUE/2021 from Ministerio de Ciencia, Innovación y Universidades (MICIU). P.M. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII21/00015), cofinanced by the European Regional Development Fund., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S), Peer reviewed